DHL Group has set forth an ambitious plan to invest $2.3 billion globally to enhance its capabilities in the healthcare logistics sector. This significant investment aims to capture the growing demand within life sciences and healthcare logistics markets, as well as fuel revenue growth by 50% by
The healthcare industry faces enduring supply chain challenges, which the COVID-19 pandemic has further magnified, emphasizing the urgent need for increased agility and efficiency. Persistent product shortages, rising costs, and unforeseen disruptions have underscored the necessity for a
The issue of pharmaceutical product loss within global supply chains due to poor handling results in significant economic losses, with over $35 billion lost annually. This compelling statistic sets the stage for discussing a transformative collaboration between SkyCell, an innovator in
DHL Group, the world's leading logistics provider, made a strategic move by acquiring CRYOPDP, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies. This acquisition aims to bolster DHL's "Health Logistics" division by leveraging CRYOPDP's
The healthcare logistics sector is witnessing an unprecedented surge as it strives to ensure the timely and secure delivery of medical products and devices. Detailed market research conducted by Arizton has projected that the market is set to attain a substantial value of $290.73 billion by the
In the wake of the devastating Syrian crisis, Jordan found itself at the epicenter of a humanitarian challenge that not only tested its resources but also its healthcare infrastructure. With an influx of Syrian refugees, Jordan's healthcare system faced unprecedented strain. Leveraging a €43 m
